Clinical Efficacy and Cost-Effectiveness of β-Lactam/β-Lactamase Inhibitor Combinations and Carbapenems in Liver Cirrhosis Patients with Gram-Negative Bacteria Bloodstream Infection
2020 ◽
Vol 23
◽
pp. 102-107
2008 ◽
Vol 29
(1)
◽
pp. 51-56
◽
2020 ◽
Vol 39
(11)
◽
pp. 2121-2131
1984 ◽
Vol 144
(1)
◽
pp. 57-62
◽
Keyword(s):
2004 ◽
Vol 53
(4)
◽
pp. 616-619
◽
2011 ◽
Vol 17
(6)
◽
pp. 876-879
◽